BenevolentAI

Merck KGaA AI drug discovery, BenevolentAI Exscientia collaboration, AI platforms for small molecules, Merck KGaA oncology immunology targets, BenevolentAI Exscientia milestones and royalties, AI-enabled drug discovery challenges, Merck KGaA stock price MRK,
Latest News Deals Pharma

Merck KGaA signs two deals with BenevolentAI and Exscientia to boost AI-driven drug discovery in oncology and immunology

Anika Sharma

Merck KGaA is making strategic moves in the field of AI-enabled drug discovery by entering into three-target partnerships with BenevolentAI ...

Pharmtales - your go-to source for comprehensive coverage of the pharmaceutical industry.

pharmtales
Latest Pharma News & Insights

© 2024 pharmtales.com | All rights reserved.

PRIVACY POLICY terms of service Contact us